Abstract Submission / Call for Abstracts

General Information

The deadline for abstract submission is 12 noon (Qatar Time) on Saturday, 15 May 2021. Please review guidelines below prior to abstract submission.

Abstract Submission Guidelines

Abstract Type/Format

Abstracts can be Scientific/Research OR Educational exhibit, and should be submitted in English (Up to 400 words) for a 5-min oral presentation in the following format:


  • Objectives 
  • Materials & Methods 
  • Results 
  • Conclusion 


  • Objectives
  • Background
  • Findings and/or Procedure Details
  • Conclusion

Abstracts should be sent to the following email: APattassery@hamad.qa

All abstracts will be reviewed and decided upon by the Scientific Committee, decision notification will be communicated via email.

Select an informative topic for your abstract. Abstract review and decision will be based on the topic.

The abstract must be submitted by the presenting author.

Contact information (incl. email address) are required for the presenting author.

There is no limit to the number of abstracts authors may submit. Please ensure all details of the presenting author and co-authors are included.

The presenting author of accepted abstracts must complete his/her registration for the conference as a delegate on the conference website when it launches before the registration deadline.

Please indicate potential conflicts of interest for all authors and outline all relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services may be related to the subject matter.

Abstracts of accepted research presentations will be published online in the conference archive viewing platform.

If you wish to edit or withdraw your abstract after the submission, or if you have any questions, please send us an email to DTan1@hamad.qa or APattassery@hamad.qa.


The organizers of this event take no responsibility for the abstracts submitted, any issues arising from the abstracts are the responsibility of the authors.

By submitting their work, the author(s) consent to publishing the abstracts on the conference website and potentially in the Clinical Imaging Department Newsletter, and transfer and assign the rights to prepare derived works such as press releases to the scientific planning committee. Author(s) represent and warrants that the work is original and does not infringe upon any copyright. If the work is not original, the author(s) should reference the original source and ensure all relevant permission and/or authorization for re-use has is obtained.